{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:39:25Z","timestamp":1791862765200,"version":"4.3.4"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006416","name":"Universidade Estadual De Campinas","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006416","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Androgen deprivation therapy (ADT) is recommended for treating prostate cancer (PCa) that relapses after first-line approaches. However, tumors often evolve to a highly aggressive and metastatic castration-resistant phenotype (CRPC). Epithelial-to-mesenchymal transition (EMT) stands out due to its contribution to hormone resistance and metastatic spread. We investigated the potential of a jaboticaba peel extract (JPE) as an adjuvant agent in CRPC tumors from the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) model, focusing on EMT regulation. Sixteen-week-old mice underwent surgical and chemical castration (10 mg\/Kg enzalutamide), alone or in combination with JPE (5.8 g\/Kg). Control animals were sham-castrated and received either placebo or the plant extract. JPE reduced the ratio of widespread prostatic tumors in mice undergoing ADT, despite not affecting metastases. It also reduced the protein levels of the EMT drivers ZEB1 and N-Cadherin, apart from contributing to the maintenance of a periacinar layer primarily composed of smooth muscle cells. Mechanistically, JPE-induced effects in castrated mice involved decrease of AR protein expression as well as ER\u03b2 beneficial actions, which included a putative stimulation of TGF-\u03b2 tumor-suppressive actions. In conclusion, JPE prevented the progression of poorly differentiated tumors with CRPC traits in the TRAMP model by hampering EMT and modulating steroid hormone and TGF-\u03b2 signaling.<\/jats:p>","DOI":"10.1007\/s10735-026-10851-x","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:56:14Z","timestamp":1782104174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Jaboticaba peel extract limits castration-resistant prostate cancer aggressiveness by counteracting EMT through steroid hormone and TGF-\u03b2 signaling modulation"],"prefix":"10.1007","volume":"57","author":[{"given":"Fabiana Regina","family":"Schievano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline","family":"de Souza Gianchetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Rabelo","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio Roberto","family":"Mar\u00f3stica J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ria Helena Alves","family":"Cagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8360-0842","authenticated-orcid":false,"given":"Fabio","family":"Montico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"10851_CR1","doi-asserted-by":"publisher","first-page":"16711","DOI":"10.1002\/jcb.28929","volume":"120","author":"A Abazid","year":"2019","unstructured":"Abazid A, Martin B, Choinowski A et al (2019) The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor \u03b21 expression in prostate cancer cells. J Cell Biochem 120:16711\u201316722. https:\/\/doi.org\/10.1002\/jcb.28929","journal-title":"J Cell Biochem"},{"key":"10851_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124449","author":"TO Adekoya","year":"2020","unstructured":"Adekoya TO, Richardson RM (2020) Cytokines and chemokines as mediators of prostate cancer metastasis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21124449","journal-title":"Int J Mol Sci"},{"key":"10851_CR3","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1158\/1078-0432.CCR-08-2332","volume":"15","author":"VM Adhami","year":"2009","unstructured":"Adhami VM, Siddiqui IA, Sarfaraz S et al (2009) Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clin Cancer Res 15:1947\u20131953. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-2332","journal-title":"Clin Cancer Res"},{"key":"10851_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/nu9080911","author":"H Amawi","year":"2017","unstructured":"Amawi H, Ashby CR, Samuel T et al (2017) Polyphenolic nutrients in cancer chemoprevention and metastasis: role of the epithelial-to-mesenchymal (EMT) pathway. Nutrients. https:\/\/doi.org\/10.3390\/nu9080911","journal-title":"Nutrients"},{"key":"10851_CR5","doi-asserted-by":"publisher","unstructured":"Avenda\u00f1o L\u00f3pez C, Menendez JC (2015) anticancer drugs that modulate hormone action, pp 81\u2013131 https:\/\/doi.org\/10.1016\/B978-0-12-818549-0.00006-6","DOI":"10.1016\/B978-0-12-818549-0.00006-6"},{"key":"10851_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.791272","author":"AB Baba","year":"2022","unstructured":"Baba AB, Rah B, Bhat GR et al (2022) Transforming growth factor-beta (TGF-\u03b2) signaling in cancer-a betrayal within. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.791272","journal-title":"Front Pharmacol"},{"key":"10851_CR7","doi-asserted-by":"publisher","first-page":"nrs-06001","DOI":"10.1621\/nrs.06001","volume":"6","author":"SP Balk","year":"2008","unstructured":"Balk SP, Knudsen KE (2008) AR, the cell cycle, and prostate cancer. Nucl Recept Signal 6:nrs-06001. https:\/\/doi.org\/10.1621\/nrs.06001","journal-title":"Nucl Recept Signal"},{"key":"10851_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0092-8674(02)00622-0","volume":"108","author":"A Balmain","year":"2002","unstructured":"Balmain A (2002) Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell 108:145\u2013152. https:\/\/doi.org\/10.1016\/S0092-8674(02)00622-0","journal-title":"Cell"},{"key":"10851_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.eururo.2003.09.001","volume":"45","author":"J Bektic","year":"2004","unstructured":"Bektic J, Berger AP, Pfeil K et al (2004) Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor \u03b2. Eur Urol 45:245\u2013251. https:\/\/doi.org\/10.1016\/j.eururo.2003.09.001","journal-title":"Eur Urol"},{"key":"10851_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184653","author":"S Belluti","year":"2023","unstructured":"Belluti S, Imbriano C, Casarini L (2023) Nuclear estrogen receptors in prostate cancer: from genes to function. Cancers. https:\/\/doi.org\/10.3390\/cancers15184653","journal-title":"Cancers"},{"key":"10851_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/0192623311425062","volume":"40","author":"LD Berman-Booty","year":"2011","unstructured":"Berman-Booty LD, Sargeant AM, Rosol TJ et al (2011) A review of the existing grading schemes and a proposal for a modified grading scheme for prostatic lesions in TRAMP mice. Toxicol Pathol 40:5\u201317. https:\/\/doi.org\/10.1177\/0192623311425062","journal-title":"Toxicol Pathol"},{"key":"10851_CR12","doi-asserted-by":"publisher","first-page":"36442","DOI":"10.1074\/jbc.M504945200","volume":"280","author":"IM Berquin","year":"2005","unstructured":"Berquin IM, Min Y, Wu R et al (2005) Expression signature of the mouse prostate. J Biol Chem 280:36442\u201336451. https:\/\/doi.org\/10.1074\/jbc.M504945200","journal-title":"J Biol Chem"},{"key":"10851_CR13","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.4161\/cc.7.21.6969","volume":"7","author":"B Bin Hafeez","year":"2008","unstructured":"Bin Hafeez B, Asim M, Siddiqui IA et al (2008) Delphinidin, a dietary anthocyanidin in pigmented fruits and vegetables: a new weapon to blunt prostate cancer growth. Cell Cycle 7:3320\u20133326. https:\/\/doi.org\/10.4161\/cc.7.21.6969","journal-title":"Cell Cycle"},{"key":"10851_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/pros.23446","volume":"78","author":"H Bonkhoff","year":"2018","unstructured":"Bonkhoff H (2018) Estrogen receptor signaling in prostate cancer: implications for carcinogenesis and tumor progression. Prostate 78:2\u201310. https:\/\/doi.org\/10.1002\/pros.23446","journal-title":"Prostate"},{"key":"10851_CR15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/carcin\/bgv084","volume":"36","author":"LJ Burton","year":"2015","unstructured":"Burton LJ, Smith BA, Smith BN et al (2015) Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. Carcinogenesis 36:1019\u20131027. https:\/\/doi.org\/10.1093\/carcin\/bgv084","journal-title":"Carcinogenesis"},{"key":"10851_CR16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.21037\/tau.2020.03.02","volume":"9","author":"Q Cai","year":"2020","unstructured":"Cai Q, Chen Y, Zhang D et al (2020) Loss of epithelial AR increase castration resistant stem-like prostate cancer cells and promotes cancer metastasis via TGF-\u03b21\/ EMT pathway. Transl Androl Urol 9:1013\u20131027. https:\/\/doi.org\/10.21037\/tau.2020.03.02","journal-title":"Transl Androl Urol"},{"key":"10851_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ajur.2015.04.011","volume":"2","author":"Z Cao","year":"2015","unstructured":"Cao Z, Kyprianou N (2015) Mechanisms navigating the TGF-\u03b2 pathway in prostate cancer. Asian J Urol 2:11\u201318. https:\/\/doi.org\/10.1016\/j.ajur.2015.04.011","journal-title":"Asian J Urol"},{"key":"10851_CR18","doi-asserted-by":"publisher","first-page":"109320","DOI":"10.1016\/j.biopha.2019.109320","volume":"118","author":"Z-Q Cao","year":"2019","unstructured":"Cao Z-Q, Wang Z, Leng P (2019) Aberrant N-cadherin expression in cancer. Biomed Pharmacother 118:109320. https:\/\/doi.org\/10.1016\/j.biopha.2019.109320","journal-title":"Biomed Pharmacother"},{"key":"10851_CR19","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1158\/0008-5472.CAN-18-3637","volume":"80","author":"M Cerasuolo","year":"2020","unstructured":"Cerasuolo M, Maccarinelli F, Coltrini D et al (2020) Modeling acquired resistance to the second-generation androgen receptor antagonist Enzalutamide in the TRAMP model of prostate cancer. Cancer Res 80:1564. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3637","journal-title":"Cancer Res"},{"key":"10851_CR20","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1124\/jpet.119.261040","volume":"371","author":"J Cheng","year":"2019","unstructured":"Cheng J, Moore S, Gomez-Galeno J et al (2019) A novel small molecule inhibits tumor growth and synergizes effects of enzalutamide on prostate cancer. J Pharmacol Exp Ther 371:703. https:\/\/doi.org\/10.1124\/jpet.119.261040","journal-title":"J Pharmacol Exp Ther"},{"key":"10851_CR21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2353\/ajpath.2008.070602","volume":"172","author":"T Chiaverotti","year":"2008","unstructured":"Chiaverotti T, Couto SS, Donjacour A et al (2008) Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer. Am J Pathol 172:236\u2013246. https:\/\/doi.org\/10.2353\/ajpath.2008.070602","journal-title":"Am J Pathol"},{"key":"10851_CR22","doi-asserted-by":"publisher","first-page":"21984","DOI":"10.1038\/s41598-021-01003-0","volume":"11","author":"JD Choi","year":"2021","unstructured":"Choi JD, Kim TJ, Jeong BC et al (2021) ISL1 promotes Enzalutamide resistance in castration-resistant prostate cancer (CRPC) through epithelial to mesenchymal transition (EMT). Sci Rep 11:21984. https:\/\/doi.org\/10.1038\/s41598-021-01003-0","journal-title":"Sci Rep"},{"key":"10851_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2119\/molmed.2014.00105","volume":"20","author":"P Christoforou","year":"2014","unstructured":"Christoforou P, Christopoulos PF, Koutsilieris M (2014) The role of estrogen receptor \u03b2 in prostate cancer. Mol Med 20:427\u2013434. https:\/\/doi.org\/10.2119\/molmed.2014.00105","journal-title":"Mol Med"},{"key":"10851_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092624","author":"M Cipolletti","year":"2018","unstructured":"Cipolletti M, Solar Fernandez V, Montalesi E et al (2018) Beyond the antioxidant activity of dietary polyphenols in cancer: the modulation of estrogen receptors (ERs) signaling. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19092624","journal-title":"Int J Mol Sci"},{"key":"10851_CR25","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.nutres.2015.07.003","volume":"35","author":"LE Conlon","year":"2015","unstructured":"Conlon LE, Wallig MA, Erdman JW (2015) Low-lycopene containing tomato powder diet does not protect against prostate cancer in TRAMP mice. Nutr Res 35:882\u2013890. https:\/\/doi.org\/10.1016\/j.nutres.2015.07.003","journal-title":"Nutr Res"},{"key":"10851_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1158\/1541-7786.MCR-12-0468","volume":"11","author":"BT Copeland","year":"2013","unstructured":"Copeland BT, Bowman MJ, Ashman LK (2013) Genetic ablation of the tetraspanin CD151 reduces spontaneous metastatic spread of prostate cancer in the TRAMP model. Mol Cancer Res 11:95\u2013105. https:\/\/doi.org\/10.1158\/1541-7786.MCR-12-0468","journal-title":"Mol Cancer Res"},{"key":"10851_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020401","author":"T Costea","year":"2020","unstructured":"Costea T, Vlad OC, Miclea L-C et al (2020) Alleviation of multidrug resistance by flavonoid and non-flavonoid compounds in breast, lung, colorectal and prostate cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21020401","journal-title":"Int J Mol Sci"},{"key":"10851_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s40610-017-0079-1","volume":"3","author":"Z Culig","year":"2017","unstructured":"Culig Z (2017) Molecular mechanisms of Enzalutamide resistance in prostate cancer. Curr Mol Biol Rep 3:230\u2013235. https:\/\/doi.org\/10.1007\/s40610-017-0079-1","journal-title":"Curr Mol Biol Rep"},{"key":"10851_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/jcp.20147","volume":"202","author":"SL Dallas","year":"2005","unstructured":"Dallas SL, Zhao S, Cramer SD et al (2005) Preferential production of latent transforming growth factor \u03b2-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen. J Cell Physiol 202:361\u2013370. https:\/\/doi.org\/10.1002\/jcp.20147","journal-title":"J Cell Physiol"},{"key":"10851_CR30","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ejca.2004.12.027","volume":"41","author":"D Danielpour","year":"2005","unstructured":"Danielpour D (2005) Functions and regulation of transforming growth factor-beta (TGF-&#x3b2;) in the prostate. Eur J Cancer 41:846\u2013857. https:\/\/doi.org\/10.1016\/j.ejca.2004.12.027","journal-title":"Eur J Cancer"},{"key":"10851_CR31","doi-asserted-by":"publisher","first-page":"188748","DOI":"10.1016\/j.bbcan.2022.188748","volume":"1877","author":"E de Arruda Nascimento","year":"2022","unstructured":"de Arruda Nascimento E, de Lima Coutinho L, da Silva CJ et al (2022) In vitro anticancer properties of anthocyanins: a systematic review. Biochim Biophys Acta BBA Rev Cancer 1877:188748. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188748","journal-title":"Biochim Biophys Acta BBA Rev Cancer"},{"key":"10851_CR32","doi-asserted-by":"publisher","first-page":"104894","DOI":"10.1016\/j.tifs.2025.104894","volume":"157","author":"\u00c1C de Souza","year":"2025","unstructured":"de Souza \u00c1C, Geraldi MV, Marostica Junior MR (2025) Jaboticaba berry: metabolic benefits, bioactive compounds, and opportunities for commercialization. Trends Food Sci Technol 157:104894. https:\/\/doi.org\/10.1016\/j.tifs.2025.104894","journal-title":"Trends Food Sci Technol"},{"key":"10851_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12943-017-0631-x","volume":"16","author":"D Delgado-Bellido","year":"2017","unstructured":"Delgado-Bellido D, Serrano-Saenz S, Fern\u00e1ndez-Cort\u00e9s M, Oliver FJ (2017) Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin. Mol Cancer 16:65. https:\/\/doi.org\/10.1186\/s12943-017-0631-x","journal-title":"Mol Cancer"},{"key":"10851_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/ng1001-117","volume":"29","author":"R Derynck","year":"2001","unstructured":"Derynck R, Akhurst RJ, Balmain A (2001) TGF-\u03b2 signaling in tumor suppression and cancer progression. Nat Genet 29:117\u2013129. https:\/\/doi.org\/10.1038\/ng1001-117","journal-title":"Nat Genet"},{"key":"10851_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ajur.2018.11.001","volume":"6","author":"H Dicken","year":"2019","unstructured":"Dicken H, Hensley PJ, Kyprianou N (2019) Prostate tumor neuroendocrine differentiation via EMT: the road less traveled. Asian J Urol 6:82\u201390. https:\/\/doi.org\/10.1016\/j.ajur.2018.11.001","journal-title":"Asian J Urol"},{"key":"10851_CR36","first-page":"163","volume":"36","author":"DCSJ Domeneghini","year":"2011","unstructured":"Domeneghini DCSJ, Lemes SAdeF (2011) Wine components and cardiovascular function. Nutrire 36:163\u2013176","journal-title":"Nutrire"},{"key":"10851_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA (2019) New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 20:69\u201384. https:\/\/doi.org\/10.1038\/s41580-018-0080-4","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10851_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/ajco.13108","volume":"15","author":"D Fang","year":"2019","unstructured":"Fang D, Zhou L (2019) Androgen deprivation therapy in nonmetastatic prostate cancer patients: indications, treatment effects, and new predictive biomarkers. Asia Pac J Clin Oncol 15:108\u2013120. https:\/\/doi.org\/10.1111\/ajco.13108","journal-title":"Asia Pac J Clin Oncol"},{"key":"10851_CR39","doi-asserted-by":"publisher","first-page":"109036","DOI":"10.1016\/j.steroids.2022.109036","volume":"184","author":"S Gadkar","year":"2022","unstructured":"Gadkar S, Thakur M, Desouza J et al (2022) Estrogen receptor expression is modulated in human and mouse prostate epithelial cells during cancer progression. Steroids 184:109036. https:\/\/doi.org\/10.1016\/j.steroids.2022.109036","journal-title":"Steroids"},{"key":"10851_CR40","doi-asserted-by":"crossref","unstructured":"Gehrig J, Kaulfu\u00df S, Jarry H et al (2017) Prospects of estrogen receptor \u03b2 activation in the treatment of castration-resistant prostate cancer","DOI":"10.18632\/oncotarget.16496"},{"key":"10851_CR41","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.1158\/0008-5472.CAN-16-2636","volume":"76","author":"IH Gelman","year":"2016","unstructured":"Gelman IH (2016) How the TRAMP model revolutionized the study of prostate cancer progression. Cancer Res 76:6137\u20136139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2636","journal-title":"Cancer Res"},{"key":"10851_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/sj.pcan.4500296","volume":"2","author":"JR Gingrich","year":"1999","unstructured":"Gingrich JR, Barrios RJ, Foster BA, Greenberg NM (1999) Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer Prostatic Dis 2:70\u201375. https:\/\/doi.org\/10.1038\/sj.pcan.4500296","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10851_CR43","first-page":"4687","volume":"57","author":"JR Gingrich","year":"1997","unstructured":"Gingrich JR, Barrios RJ, Kattan MW et al (1997) Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res 57:4687","journal-title":"Cancer Res"},{"key":"10851_CR44","first-page":"4096","volume":"56","author":"JR Gingrich","year":"1996","unstructured":"Gingrich JR, Barrios RJ, Morton RA et al (1996) Metastatic prostate cancer in a transgenic mouse1. Cancer Res 56:4096\u20134102","journal-title":"Cancer Res"},{"key":"10851_CR45","doi-asserted-by":"publisher","first-page":"e109208","DOI":"10.1371\/journal.pone.0109208","volume":"9","author":"AL Gray","year":"2014","unstructured":"Gray AL, Stephens CA, Bigelow RLH et al (2014) The polyphenols (\u2212)-Epigallocatechin-3-Gallate and Luteolin synergistically inhibit TGF-\u03b2-induced myofibroblast phenotypes through RhoA and ERK inhibition. PLoS ONE 9:e109208","journal-title":"PLoS ONE"},{"key":"10851_CR46","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1073\/pnas.92.8.3439","volume":"92","author":"NM Greenberg","year":"1995","unstructured":"Greenberg NM, DeMayo F, Finegold MJ et al (1995) Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92:3439\u20133443. https:\/\/doi.org\/10.1073\/pnas.92.8.3439","journal-title":"Proc Natl Acad Sci USA"},{"key":"10851_CR47","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/pros.22674","volume":"73","author":"J Guerrero","year":"2013","unstructured":"Guerrero J, Alfaro IE, G\u00f3mez F et al (2013) Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer. Prostate 73:1291\u20131305. https:\/\/doi.org\/10.1002\/pros.22674","journal-title":"Prostate"},{"key":"10851_CR48","doi-asserted-by":"publisher","first-page":"10350","DOI":"10.1073\/pnas.171326098","volume":"98","author":"S Gupta","year":"2001","unstructured":"Gupta S, Hastak K, Ahmad N et al (2001) Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 98:10350\u201310355. https:\/\/doi.org\/10.1073\/pnas.171326098","journal-title":"Proc Natl Acad Sci USA"},{"key":"10851_CR49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3349\/ymj.2015.56.1.16","volume":"56","author":"U-S Ha","year":"2015","unstructured":"Ha U-S, Bae WJ, Kim SJ et al (2015) Anthocyanin induces apoptosis of DU-145 cells in vitro and inhibits xenograft growth of prostate cancer. Yonsei Med J 56:16\u201323","journal-title":"Yonsei Med J"},{"key":"10851_CR50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/152165400300001471","volume":"50","author":"SM Hadi","year":"2000","unstructured":"Hadi SM, Asad SF, Singh S, Ahmad A (2000) Putative mechanism for anticancer and apoptosis-inducing properties of plant-derived polyphenolic compounds. IUBMB Life 50:167\u2013171. https:\/\/doi.org\/10.1080\/152165400300001471","journal-title":"IUBMB Life"},{"key":"10851_CR51","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41576-023-00601-0","volume":"24","author":"J Haerinck","year":"2023","unstructured":"Haerinck J, Goossens S, Berx G (2023) The epithelial\u2013mesenchymal plasticity landscape: principles of design and mechanisms of regulation. Nat Rev Genet 24:590\u2013609. https:\/\/doi.org\/10.1038\/s41576-023-00601-0","journal-title":"Nat Rev Genet"},{"key":"10851_CR52","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12957-015-0648-9","volume":"13","author":"J He","year":"2015","unstructured":"He J, Wang S, Zhou M et al (2015) Phytoestrogens and risk of prostate cancer: a meta-analysis of observational studies. World J Surg Oncol 13:231. https:\/\/doi.org\/10.1186\/s12957-015-0648-9","journal-title":"World J Surg Oncol"},{"key":"10851_CR53","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1593\/neo.07562","volume":"9","author":"W Huss","year":"2007","unstructured":"Huss W, Gray D, Tavakoli K et al (2007) Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model 1, 2. Neoplasia 9:938\u2013950. https:\/\/doi.org\/10.1593\/neo.07562","journal-title":"Neoplasia"},{"key":"10851_CR54","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s10147-019-01554-3","volume":"25","author":"T Iguchi","year":"2020","unstructured":"Iguchi T, Tamada S, Kato M et al (2020) Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study. Int J Clin Oncol 25:486\u2013494. https:\/\/doi.org\/10.1007\/s10147-019-01554-3","journal-title":"Int J Clin Oncol"},{"key":"10851_CR55","doi-asserted-by":"publisher","first-page":"110518","DOI":"10.1016\/j.foodres.2021.110518","volume":"147","author":"KOP Inada","year":"2021","unstructured":"Inada KOP, Leite IB, Martins ABN et al (2021) Jaboticaba berry: a comprehensive review on its polyphenol composition, health effects, metabolism, and the development of food products. Food Res Int 147:110518. https:\/\/doi.org\/10.1016\/j.foodres.2021.110518","journal-title":"Food Res Int"},{"key":"10851_CR56","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James ND, Tannock I, N\u2019Dow J et al (2024) The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet 403:1683\u20131722. https:\/\/doi.org\/10.1016\/S0140-6736(24)00651-2","journal-title":"Lancet"},{"key":"10851_CR57","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/pros.20148","volume":"62","author":"MA Johnson","year":"2005","unstructured":"Johnson MA, Iversen P, Schwier P et al (2005) Castration triggers growth of previously static androgen-independent lesions in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Prostate 62:322\u2013338. https:\/\/doi.org\/10.1002\/pros.20148","journal-title":"Prostate"},{"key":"10851_CR58","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000515289","volume":"211","author":"MK Jolly","year":"2021","unstructured":"Jolly MK, Murphy RJ, Bhatia S et al (2021) Measuring and modelling the epithelial- mesenchymal hybrid state in cancer: clinical implications. Cells Tissues Organs 211:110\u2013133. https:\/\/doi.org\/10.1159\/000515289","journal-title":"Cells Tissues Organs"},{"key":"10851_CR59","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.semcancer.2016.06.003","volume":"40\u201341","author":"G Kallifatidis","year":"2016","unstructured":"Kallifatidis G, Hoy JJ, Lokeshwar BL (2016) Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer. Semin Cancer Biol 40\u201341:160\u2013169. https:\/\/doi.org\/10.1016\/j.semcancer.2016.06.003","journal-title":"Semin Cancer Biol"},{"key":"10851_CR60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/pros.10215","volume":"55","author":"PJ Kaplan-Lefko","year":"2003","unstructured":"Kaplan-Lefko PJ, Chen T-M, Ittmann MM et al (2003) Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 55:219\u2013237. https:\/\/doi.org\/10.1002\/pros.10215","journal-title":"Prostate"},{"key":"10851_CR61","doi-asserted-by":"crossref","unstructured":"Kawahara T, Inoue S, Kashiwagi E et al (2017) Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis","DOI":"10.1016\/j.juro.2016.02.2202"},{"key":"10851_CR62","doi-asserted-by":"publisher","first-page":"87","DOI":"10.15430\/JCP.2020.25.2.87","volume":"25","author":"LA Kido","year":"2020","unstructured":"Kido LA, Hahm E-R, Kim S-H et al (2020) Prevention of prostate cancer in transgenic adenocarcinoma of the mouse prostate mice by yellow passion fruit extract and antiproliferative effects of its bioactive compound piceatannol. J Cancer Prev 25:87\u201399. https:\/\/doi.org\/10.15430\/JCP.2020.25.2.87","journal-title":"J Cancer Prev"},{"key":"10851_CR63","doi-asserted-by":"publisher","first-page":"182","DOI":"10.15430\/jcp.2022.27.3.182","volume":"27","author":"LA Kido","year":"2022","unstructured":"Kido LA, Rossetto IMU, Baseggio AM et al (2022) Brazilian berry extract differentially induces inflammatory and immune responses in androgen dependent and independent prostate cancer cells. J Cancer Prev 27:182\u2013191. https:\/\/doi.org\/10.15430\/jcp.2022.27.3.182","journal-title":"J Cancer Prev"},{"key":"10851_CR64","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1158\/1940-6207.CAPR-13-0427-T","volume":"7","author":"SJ Kim","year":"2014","unstructured":"Kim SJ, Amankwah E, Connors S et al (2014) Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice. Cancer Prev Res 7:435\u2013444. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-13-0427-T","journal-title":"Cancer Prev Res"},{"key":"10851_CR65","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/pros.21190","volume":"70","author":"R Konijeti","year":"2010","unstructured":"Konijeti R, Henning S, Moro A et al (2010) Chemoprevention of prostate cancer with lycopene in the TRAMP model. Prostate 70:1547\u20131554. https:\/\/doi.org\/10.1002\/pros.21190","journal-title":"Prostate"},{"key":"10851_CR66","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/bcr42","volume":"2","author":"M Kretzschmar","year":"2000","unstructured":"Kretzschmar M (2000) Transforming growth factor-\u03b2 and breast cancer: transforming growth factor-\u03b2\/SMAD signaling defects and cancer. Breast Cancer Res 2:107. https:\/\/doi.org\/10.1186\/bcr42","journal-title":"Breast Cancer Res"},{"key":"10851_CR67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0002-9343(01)00995-0","volume":"113","author":"PM Kris-Etherton","year":"2002","unstructured":"Kris-Etherton PM, Hecker KD, Bonanome A et al (2002) Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 113:71\u201388. https:\/\/doi.org\/10.1016\/S0002-9343(01)00995-0","journal-title":"Am J Med"},{"key":"10851_CR68","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1039\/C9FO02621E","volume":"11","author":"CA Lamas","year":"2020","unstructured":"Lamas CA, Kido LA, Montico F et al (2020) A jaboticaba extract prevents prostatic damage associated with aging and high-fat diet intake. Food Funct 11:1547\u20131559. https:\/\/doi.org\/10.1039\/C9FO02621E","journal-title":"Food Funct"},{"key":"10851_CR69","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jff.2018.06.005","volume":"47","author":"CA Lamas","year":"2018","unstructured":"Lamas CA, Lenquiste SA, Baseggio AM et al (2018) Jaboticaba extract prevents prediabetes and liver steatosis in high-fat-fed aging mice. J Funct Foods 47:434\u2013446. https:\/\/doi.org\/10.1016\/j.jff.2018.06.005","journal-title":"J Funct Foods"},{"key":"10851_CR70","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.semcancer.2022.09.004","volume":"86","author":"JH Lee","year":"2022","unstructured":"Lee JH, Massagu\u00e9 J (2022) TGF-\u03b2 in developmental and fibrogenic EMTs. Semin Cancer Biol 86:136\u2013145. https:\/\/doi.org\/10.1016\/j.semcancer.2022.09.004","journal-title":"Semin Cancer Biol"},{"key":"10851_CR71","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.foodres.2012.07.044","volume":"49","author":"AV Leite-Legatti","year":"2012","unstructured":"Leite-Legatti AV, Batista \u00c2G, Dragano NRV et al (2012) Jaboticaba peel: Antioxidant compounds, antiproliferative and antimutagenic activities. Food Res Int 49:596\u2013603. https:\/\/doi.org\/10.1016\/j.foodres.2012.07.044","journal-title":"Food Res Int"},{"key":"10851_CR72","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bcp.2015.07.017","volume":"98","author":"AJ Le\u00f3n-Gonz\u00e1lez","year":"2015","unstructured":"Le\u00f3n-Gonz\u00e1lez AJ, Auger C, Schini-Kerth VB (2015) Pro-oxidant activity of polyphenols and its implication on cancer chemoprevention and chemotherapy. Biochem Pharmacol 98:371\u2013380. https:\/\/doi.org\/10.1016\/j.bcp.2015.07.017","journal-title":"Biochem Pharmacol"},{"key":"10851_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1542811","author":"C Li","year":"2025","unstructured":"Li C, Cheng D, Li P (2025) Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2025.1542811","journal-title":"Front Oncol"},{"key":"10851_CR74","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/bph.13627","volume":"174","author":"B-W Lin","year":"2017","unstructured":"Lin B-W, Gong C-C, Song H-F, Cui Y-Y (2017) Effects of anthocyanins on the prevention and treatment of cancer. Br J Pharmacol 174:1226\u20131243. https:\/\/doi.org\/10.1111\/bph.13627","journal-title":"Br J Pharmacol"},{"key":"10851_CR75","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12929-020-00632-3","volume":"27","author":"Y-T Lin","year":"2020","unstructured":"Lin Y-T, Wu K-J (2020) Epigenetic regulation of epithelial-mesenchymal transition: focusing on hypoxia and TGF-\u03b2 signaling. J Biomed Sci 27:39. https:\/\/doi.org\/10.1186\/s12929-020-00632-3","journal-title":"J Biomed Sci"},{"key":"10851_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01110","author":"M Liu","year":"2019","unstructured":"Liu M, Du Y, Li H et al (2019) Cyanidin-3-o-Glucoside pharmacologically inhibits tumorigenesis via estrogen receptor \u03b2 in melanoma mice. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2019.01110","journal-title":"Front Oncol"},{"key":"10851_CR77","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/cas.12078","volume":"104","author":"N Long","year":"2013","unstructured":"Long N, Suzuki S, Sato S et al (2013) Purple corn color inhibition of prostate carcinogenesis by targeting cell growth pathways. Cancer Sci 104:298\u2013303. https:\/\/doi.org\/10.1111\/cas.12078","journal-title":"Cancer Sci"},{"key":"10851_CR78","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/(SICI)1097-4652(199805)175:2<184::AID-JCP8>3.0.CO;2-K","volume":"175","author":"MS Lucia","year":"1998","unstructured":"Lucia MS, Sporn MB, Roberts AB et al (1998) The role of transforming growth factor-\u03b21, -\u03b22, and -\u03b23 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells. J Cell Physiol 175:184\u2013192","journal-title":"J Cell Physiol"},{"key":"10851_CR79","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13045-020-00858-6","volume":"13","author":"Q Luo","year":"2020","unstructured":"Luo Q, Wang J, Zhao W et al (2020) Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol Oncol 13:19. https:\/\/doi.org\/10.1186\/s13045-020-00858-6","journal-title":"J Hematol Oncol"},{"key":"10851_CR80","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.7150\/ijbs.123812","volume":"22","author":"C Ma","year":"2026","unstructured":"Ma C, Yang L, Li W et al (2026) The role of estrogen signaling pathway and targeted therapy exploration in urological tumors. Int J Biol Sci 22:1207\u20131232. https:\/\/doi.org\/10.7150\/ijbs.123812","journal-title":"Int J Biol Sci"},{"key":"10851_CR81","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccr.2010.02.030","volume":"17","author":"P Mak","year":"2010","unstructured":"Mak P, Leav I, Pursell B et al (2010) ER\u03b2 impedes prostate cancer EMT by destabilizing HIF-1\u03b1 and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell 17:319\u2013332. https:\/\/doi.org\/10.1016\/j.ccr.2010.02.030","journal-title":"Cancer Cell"},{"key":"10851_CR82","unstructured":"Mar\u00f3stica J\u00fanior M, Quitete VHAC, Lamas C de A et al (2017) Composi\u00e7\u00e3o compreendendo extrato da casca de jabuticaba, e usos da mesma"},{"key":"10851_CR83","first-page":"6777","volume":"61","author":"R Mentor-Marcel","year":"2001","unstructured":"Mentor-Marcel R, Lamartiniere CA, Eltoum I-E et al (2001) Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP)1. Cancer Res 61:6777\u20136782","journal-title":"Cancer Res"},{"key":"10851_CR84","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1158\/0008-5472.CAN-16-2169","volume":"77","author":"L Miao","year":"2017","unstructured":"Miao L, Yang L, Li R et al (2017) Disrupting androgen receptor signaling induces snail-mediated epithelial-mesenchymal plasticity in prostate cancer. Cancer Res 77:3101\u20133112. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2169","journal-title":"Cancer Res"},{"key":"10851_CR85","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10911-010-9178-9","volume":"15","author":"DS Micalizzi","year":"2010","unstructured":"Micalizzi DS, Farabaugh SM, Ford HL (2010a) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15:117\u2013134. https:\/\/doi.org\/10.1007\/s10911-010-9178-9","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10851_CR86","doi-asserted-by":"publisher","first-page":"10371","DOI":"10.1158\/0008-5472.CAN-10-1354","volume":"70","author":"DS Micalizzi","year":"2010","unstructured":"Micalizzi DS, Wang C-A, Farabaugh SM et al (2010b) Homeoprotein Six1 increases TGF-\u03b2 Type I receptor and converts TGF-\u03b2 signaling from suppressive to supportive for tumor growth. Cancer Res 70:10371\u201310380. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1354","journal-title":"Cancer Res"},{"key":"10851_CR87","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/mnfr.200600271","volume":"51","author":"J Milde","year":"2007","unstructured":"Milde J, Elstner EF, Gra\u00dfmann J (2007) Synergistic effects of phenolics and carotenoids on human low-density lipoprotein oxidation. Mol Nutr Food Res 51:956\u2013961. https:\/\/doi.org\/10.1002\/mnfr.200600271","journal-title":"Mol Nutr Food Res"},{"key":"10851_CR88","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1038\/onc.2013.374","volume":"33","author":"S Mishra","year":"2014","unstructured":"Mishra S, Deng JJ, Gowda PS et al (2014) Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer. Oncogene 33:4097\u20134106. https:\/\/doi.org\/10.1038\/onc.2013.374","journal-title":"Oncogene"},{"key":"10851_CR89","volume-title":"Design and analysis of experiments","author":"DC Montgomery","year":"1991","unstructured":"Montgomery DC (1991) Design and analysis of experiments, 3rd edn. John Wiley & Sons, Inc., New York","edition":"3"},{"key":"10851_CR90","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jsbmb.2016.05.007","volume":"166","author":"M Nakazawa","year":"2017","unstructured":"Nakazawa M, Kyprianou N (2017) Epithelial-mesenchymal-transition regulators in prostate cancer: androgens and beyond. J Steroid Biochem Mol Biol 166:84\u201390. https:\/\/doi.org\/10.1016\/j.jsbmb.2016.05.007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10851_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23010074","author":"N Nanashima","year":"2018","unstructured":"Nanashima N, Horie K, Maeda H (2018) Phytoestrogenic activity of blackcurrant anthocyanins is partially mediated through estrogen receptor beta. Molecules. https:\/\/doi.org\/10.3390\/molecules23010074","journal-title":"Molecules"},{"key":"10851_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143518","author":"C Nicola","year":"2021","unstructured":"Nicola C, Dubois M, Campart C et al (2021) The prostate cancer therapy enzalutamide compared with abiraterone acetate\/prednisone impacts motivation for exploration, spatial learning and alters dopaminergic transmission in aged castrated mice. Cancers. https:\/\/doi.org\/10.3390\/cancers13143518","journal-title":"Cancers"},{"key":"10851_CR93","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1083\/jcb.147.3.631","volume":"147","author":"MT Nieman","year":"1999","unstructured":"Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ (1999) N-Cadherin promotes motility in human breast cancer cells regardless of their E-Cadherin expression. J Cell Biol 147:631\u2013644. https:\/\/doi.org\/10.1083\/jcb.147.3.631","journal-title":"J Cell Biol"},{"key":"10851_CR94","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/cas.12613","volume":"106","author":"Y Omoto","year":"2015","unstructured":"Omoto Y, Iwase H (2015) Clinical significance of estrogen receptor \u03b2 in breast and prostate cancer from biological aspects. Cancer Sci 106:337\u2013343. https:\/\/doi.org\/10.1111\/cas.12613","journal-title":"Cancer Sci"},{"key":"10851_CR95","doi-asserted-by":"publisher","first-page":"5806602","DOI":"10.1155\/2021\/5806602","volume":"2021","author":"X Pang","year":"2021","unstructured":"Pang X, Zhang J, He X et al (2021) SPP1 promotes Enzalutamide resistance and Epithelial-Mesenchymal-Transition activation in castration-resistant prostate cancer via PI3K\/AKT and ERK1\/2 pathways. Oxid Med Cell Longev 2021:5806602. https:\/\/doi.org\/10.1155\/2021\/5806602","journal-title":"Oxid Med Cell Longev"},{"key":"10851_CR96","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/1940-6207.CAPR-09-0237","volume":"3","author":"T Pannellini","year":"2010","unstructured":"Pannellini T, Iezzi M, Liberatore M et al (2010) A dietary tomato supplement prevents prostate cancer in TRAMP mice. Cancer Prev Res 3:1284\u20131291. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-09-0237","journal-title":"Cancer Prev Res"},{"key":"10851_CR97","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.phrs.2013.10.002","volume":"79","author":"M Piccolella","year":"2014","unstructured":"Piccolella M, Crippa V, Messi E et al (2014) Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells. Pharmacol Res 79:13\u201320. https:\/\/doi.org\/10.1016\/j.phrs.2013.10.002","journal-title":"Pharmacol Res"},{"key":"10851_CR98","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1210\/en.2017-00086","volume":"158","author":"H Pu","year":"2017","unstructured":"Pu H, Begemann DE, Kyprianou N (2017) Aberrant TGF-\u03b2 signaling drives castration-resistant prostate cancer in a male mouse model of prostate tumorigenesis. Endocrinology 158:1612\u20131622. https:\/\/doi.org\/10.1210\/en.2017-00086","journal-title":"Endocrinology"},{"key":"10851_CR99","doi-asserted-by":"publisher","first-page":"7366","DOI":"10.1158\/0008-5472.CAN-09-0758","volume":"69","author":"H Pu","year":"2009","unstructured":"Pu H, Collazo J, Jones E et al (2009) Dysfunctional Transforming Growth Factor-\u03b2 Receptor II accelerates prostate tumorigenesis in the TRAMP mouse model. Cancer Res 69:7366\u20137374. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-0758","journal-title":"Cancer Res"},{"key":"10851_CR100","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.trsl.2020.04.003","volume":"222","author":"LG Qu","year":"2020","unstructured":"Qu LG, Wardan H, Davis ID et al (2020) Effects of estrogen receptor signaling on prostate cancer carcinogenesis. Transl Res 222:56\u201366. https:\/\/doi.org\/10.1016\/j.trsl.2020.04.003","journal-title":"Transl Res"},{"key":"10851_CR101","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1093\/carcin\/bgm117","volume":"28","author":"L Reddivari","year":"2007","unstructured":"Reddivari L, Vanamala J, Chintharlapalli S et al (2007) Anthocyanin fraction from potato extracts is cytotoxic to prostate cancer cells through activation of caspase-dependent and caspase-independent pathways. Carcinogenesis 28:2227\u20132235. https:\/\/doi.org\/10.1093\/carcin\/bgm117","journal-title":"Carcinogenesis"},{"key":"10851_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0163-7258(03)00042-1","volume":"99","author":"L Reddy","year":"2003","unstructured":"Reddy L, Odhav B, Bhoola KD (2003) Natural products for cancer prevention: a global perspective. Pharmacol Ther 99:1\u201313. https:\/\/doi.org\/10.1016\/S0163-7258(03)00042-1","journal-title":"Pharmacol Ther"},{"key":"10851_CR103","doi-asserted-by":"publisher","first-page":"116155","DOI":"10.1016\/j.foodres.2025.116155","volume":"208","author":"BB Rezende","year":"2025","unstructured":"Rezende BB, Vecchi ACT, Mar\u00f3stica MR et al (2025) Differential effects of jaboticaba peel extract administration on PCa progression in TRAMP mice depend on the androgenic status of the prostatic milieu and are driven by angiogenesis regulation. Food Res Int 208:116155. https:\/\/doi.org\/10.1016\/j.foodres.2025.116155","journal-title":"Food Res Int"},{"key":"10851_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00801","author":"MA Rice","year":"2019","unstructured":"Rice MA, Malhotra SV, Stoyanova T (2019) Second-generation antiandrogens: from discovery to standard of care in castration resistant prostate cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2019.00801","journal-title":"Front Oncol"},{"key":"10851_CR105","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ab.2010.02.036","volume":"401","author":"I Romero-Calvo","year":"2010","unstructured":"Romero-Calvo I, Oc\u00f3n B, Mart\u00ednez-Moya P et al (2010) Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 401:318\u2013320. https:\/\/doi.org\/10.1016\/j.ab.2010.02.036","journal-title":"Anal Biochem"},{"key":"10851_CR106","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1093\/jn\/nxaa107","volume":"150","author":"JL Rowles","year":"2020","unstructured":"Rowles JL, Smith JW, Applegate CC et al (2020) Dietary tomato or lycopene do not reduce castration-resistant prostate cancer progression in a murine model. J Nutr 150:1808\u20131817. https:\/\/doi.org\/10.1093\/jn\/nxaa107","journal-title":"J Nutr"},{"key":"10851_CR107","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13045-022-01349-6","volume":"15","author":"X Shi","year":"2022","unstructured":"Shi X, Yang J, Deng S et al (2022) TGF-\u03b2 signaling in the tumor metabolic microenvironment and targeted therapies. J Hematol Oncol 15:135. https:\/\/doi.org\/10.1186\/s13045-022-01349-6","journal-title":"J Hematol Oncol"},{"key":"10851_CR108","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/carcin\/bgt316","volume":"35","author":"S Shukla","year":"2014","unstructured":"Shukla S, Bhaskaran N, Babcook MA et al (2014) Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K\/Akt\/FoxO pathway. Carcinogenesis 35:452\u2013460. https:\/\/doi.org\/10.1093\/carcin\/bgt316","journal-title":"Carcinogenesis"},{"key":"10851_CR109","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1007\/s11095-011-0625-0","volume":"29","author":"S Shukla","year":"2012","unstructured":"Shukla S, MacLennan GT, Fu P, Gupta S (2012) Apigenin attenuates Insulin-Like Growth Factor-I signaling in an autochthonous mouse prostate cancer model. Pharm Res 29:1506\u20131517. https:\/\/doi.org\/10.1007\/s11095-011-0625-0","journal-title":"Pharm Res"},{"key":"10851_CR110","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biocel.2018.01.008","volume":"96","author":"RdeS Silva","year":"2018","unstructured":"Silva RdeS, Lombardi APG, de Souza DS et al (2018) Activation of estrogen receptor beta (ER\u03b2) regulates the expression of N-cadherin, E-cadherin and \u03b2-catenin in androgen-independent prostate cancer cells. Int J Biochem Cell Biol 96:40\u201350. https:\/\/doi.org\/10.1016\/j.biocel.2018.01.008","journal-title":"Int J Biochem Cell Biol"},{"key":"10851_CR111","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1210\/en.2012-1030","volume":"153","author":"A \u015alusarz","year":"2012","unstructured":"\u015alusarz A, Jackson GA, Day JK et al (2012) Aggressive prostate cancer is prevented in ER\u03b1KO mice and stimulated in ER\u03b2KO TRAMP mice. Endocrinology 153:4160\u20134170. https:\/\/doi.org\/10.1210\/en.2012-1030","journal-title":"Endocrinology"},{"key":"10851_CR112","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.2174\/1381612828666220601153426","volume":"28","author":"M Sohel","year":"2022","unstructured":"Sohel M, Sultana H, Sultana T et al (2022) Chemotherapeutic activities of dietary phytoestrogens against prostate cancer: from observational to clinical studies. Curr Pharm des 28:1561\u20131580. https:\/\/doi.org\/10.2174\/1381612828666220601153426","journal-title":"Curr Pharm des"},{"key":"10851_CR113","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13046-017-0545-x","volume":"36","author":"W Song","year":"2017","unstructured":"Song W, Tang L, Xu Y et al (2017) ER\u03b21 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1. J Exp Clin Cancer Res 36:75. https:\/\/doi.org\/10.1186\/s13046-017-0545-x","journal-title":"J Exp Clin Cancer Res"},{"key":"10851_CR114","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3892\/ijo.2015.3130","volume":"47","author":"V Sorrenti","year":"2015","unstructured":"Sorrenti V, Vanella L, Acquaviva R et al (2015) Cyanidin induces apoptosis and differentiation in prostate cancer cells. Int J Oncol 47:1303\u20131310. https:\/\/doi.org\/10.3892\/ijo.2015.3130","journal-title":"Int J Oncol"},{"key":"10851_CR115","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.febslet.2008.01.024","volume":"582","author":"F Suenaga","year":"2008","unstructured":"Suenaga F, Hatsushika K, Takano S et al (2008) A possible link between resveratrol and TGF-\u03b2: Resveratrol induction of TGF-\u03b2 expression and signaling. FEBS Lett 582:586\u2013590. https:\/\/doi.org\/10.1016\/j.febslet.2008.01.024","journal-title":"FEBS Lett"},{"key":"10851_CR116","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1158\/0008-5472.CAN-11-3004","volume":"72","author":"Y Sun","year":"2012","unstructured":"Sun Y, Wang B-E, Leong KG et al (2012) Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy. Cancer Res 72:527\u2013536. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3004","journal-title":"Cancer Res"},{"key":"10851_CR117","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1158\/1940-6207.CAPR-15-0402","volume":"10","author":"H-L Tan","year":"2017","unstructured":"Tan H-L, Thomas-Ahner JM, Moran NE et al (2017) \u03b2-Carotene 9\u2032,10\u2032 oxygenase modulates the anticancer activity of dietary tomato or Lycopene on prostate carcinogenesis in the TRAMP model. Cancer Prev Res 10:161\u2013169. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-15-0402","journal-title":"Cancer Prev Res"},{"key":"10851_CR118","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1158\/1078-0432.CCR-07-4925","volume":"14","author":"Y Tang","year":"2008","unstructured":"Tang Y, Wang L, Goloubeva O et al (2008) Divergent effects of castration on prostate cancer in TRAMP mice: possible implications for therapy. Clin Cancer Res 14:2936\u20132943. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4925","journal-title":"Clin Cancer Res"},{"key":"10851_CR119","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jsbmb.2013.06.009","volume":"139","author":"P Thelen","year":"2014","unstructured":"Thelen P, Wuttke W, Seidlov\u00e1-Wuttke D (2014) Phytoestrogens selective for the estrogen receptor beta exert anti-androgenic effects in castration resistant prostate cancer. J Steroid Biochem Mol Biol 139:290\u2013293. https:\/\/doi.org\/10.1016\/j.jsbmb.2013.06.009","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10851_CR120","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s43556-022-00109-9","volume":"3","author":"Y Tie","year":"2022","unstructured":"Tie Y, Tang F, Peng D et al (2022) TGF-beta signal transduction: biology, function and therapy for diseases. Mol Biomed 3:45. https:\/\/doi.org\/10.1186\/s43556-022-00109-9","journal-title":"Mol Biomed"},{"key":"10851_CR121","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/carcin\/bgw039","volume":"37","author":"H Ting","year":"2016","unstructured":"Ting H, Deep G, Kumar S et al (2016) Beneficial effects of the naturally occurring flavonoid silibinin on the prostate cancer microenvironment: role of monocyte chemotactic protein-1 and immune cell recruitment. Carcinogenesis 37:589\u2013599. https:\/\/doi.org\/10.1093\/carcin\/bgw039","journal-title":"Carcinogenesis"},{"key":"10851_CR122","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/mc.22135","volume":"54","author":"HJ Ting","year":"2015","unstructured":"Ting HJ, Deep G, Jain AK et al (2015) Silibinin prevents prostate cancer cell-mediated differentiation of na\u00efve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF \u03b22. Mol Carcinog 54:730\u2013741. https:\/\/doi.org\/10.1002\/mc.22135","journal-title":"Mol Carcinog"},{"key":"10851_CR123","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1021\/jf0303924","volume":"52","author":"S Trombino","year":"2004","unstructured":"Trombino S, Serini S, Di Nicuolo F et al (2004) Antioxidant effect of Ferulic Acid in isolated membranes and intact cells: synergistic interactions with \u03b1-Tocopherol, \u03b2-Carotene, and Ascorbic Acid. J Agric Food Chem 52:2411\u20132420. https:\/\/doi.org\/10.1021\/jf0303924","journal-title":"J Agric Food Chem"},{"key":"10851_CR124","first-page":"2912","volume":"8","author":"JA Tuxhorn","year":"2002","unstructured":"Tuxhorn JA, Ayala GE, Smith MJ et al (2002) Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling1. Clin Cancer Res 8:2912\u20132923","journal-title":"Clin Cancer Res"},{"key":"10851_CR125","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/bco2.103","volume":"3","author":"H Uemura","year":"2022","unstructured":"Uemura H, Kobayashi K, Yokomizo A et al (2022) Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration-resistant prostate cancer: AFTERCAB study. BJUI Compass 3:26\u201336. https:\/\/doi.org\/10.1002\/bco2.103","journal-title":"BJUI Compass"},{"key":"10851_CR126","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13046-016-0351-x","volume":"35","author":"P Wang","year":"2016","unstructured":"Wang P, Henning SM, Magyar CE et al (2016) Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy. J Exp Clin Cancer Res 35:73. https:\/\/doi.org\/10.1186\/s13046-016-0351-x","journal-title":"J Exp Clin Cancer Res"},{"key":"10851_CR127","doi-asserted-by":"publisher","first-page":"185946","DOI":"10.1155\/2014\/185946","volume":"2014","author":"W-H Wang","year":"2014","unstructured":"Wang W-H, Tyan Y-C, Chen Z-S et al (2014) Evaluation of the antioxidant activity and antiproliferative effect of the Jaboticaba (Myrciaria cauliflora) seed extracts in oral carcinoma cells. BioMed Res Int 2014:185946. https:\/\/doi.org\/10.1155\/2014\/185946","journal-title":"BioMed Res Int"},{"key":"10851_CR128","doi-asserted-by":"publisher","unstructured":"Wang X, Xue X, Pang M et al (2024) Epithelial-mesenchymal plasticity in cancer: signaling pathways and therapeutic targets. MedComm (2020) 5:e659. https:\/\/doi.org\/10.1002\/mco2.659","DOI":"10.1002\/mco2.659"},{"key":"10851_CR129","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/bph.15300","volume":"178","author":"Y Wang","year":"2021","unstructured":"Wang Y, Chen J, Wu Z et al (2021) Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it. Br J Pharmacol 178:239\u2013261. https:\/\/doi.org\/10.1111\/bph.15300","journal-title":"Br J Pharmacol"},{"key":"10851_CR130","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12943-020-01288-1","volume":"20","author":"X Wei","year":"2021","unstructured":"Wei X, Chen Y, Jiang X et al (2021) Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer 20:7. https:\/\/doi.org\/10.1186\/s12943-020-01288-1","journal-title":"Mol Cancer"},{"key":"10851_CR131","first-page":"131","volume":"12","author":"ER Weibel","year":"1963","unstructured":"Weibel ER (1963) Principles and methods for the morphometric study of the lung and other organs. Lab Invest 12:131\u2013155","journal-title":"Lab Invest"},{"key":"10851_CR132","unstructured":"Williams RH, Stapleton AM, Yang G, et al (1996) Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study. Clin Cancer Res 2:635-640"},{"key":"10851_CR133","doi-asserted-by":"publisher","first-page":"E3816","DOI":"10.1073\/pnas.1702211114","volume":"114","author":"W Wu","year":"2017","unstructured":"Wu W, Maneix L, Insunza J et al (2017) Estrogen receptor \u03b2, a regulator of androgen receptor signaling in the mouse ventral prostate. Proc Natl Acad Sci USA 114:E3816\u2013E3822. https:\/\/doi.org\/10.1073\/pnas.1702211114","journal-title":"Proc Natl Acad Sci USA"},{"key":"10851_CR134","doi-asserted-by":"publisher","first-page":"e2505797122","DOI":"10.1073\/pnas.2505797122","volume":"122","author":"W Wu","year":"2025","unstructured":"Wu W, Song X, Warner M et al (2025) The role of estrogen receptor \u03b2 in maintaining basal cells and modulating the immune environment in the prostate. Proc Natl Acad Sci USA 122:e2505797122. https:\/\/doi.org\/10.1073\/pnas.2505797122","journal-title":"Proc Natl Acad Sci USA"},{"key":"10851_CR135","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.yexmp.2015.03.030","volume":"98","author":"Z Yang","year":"2015","unstructured":"Yang Z, Sun B, Li Y et al (2015) ZEB2 promotes vasculogenic mimicry by TGF-\u03b21 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma. Exp Mol Pathol 98:352\u2013359. https:\/\/doi.org\/10.1016\/j.yexmp.2015.03.030","journal-title":"Exp Mol Pathol"},{"key":"10851_CR136","volume-title":"Biostatistical analysis","author":"JH Zar","year":"1999","unstructured":"Zar JH (1999) Biostatistical analysis, 4th edn. Prentice Hall, Upper","edition":"4th edn"},{"key":"10851_CR137","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/andr.12196","volume":"4","author":"M Zhang","year":"2016","unstructured":"Zhang M, Wang K, Chen L et al (2016) Is phytoestrogen intake associated with decreased risk of prostate cancer? A systematic review of epidemiological studies based on 17,546 cases. Andrology 4:745\u2013756. https:\/\/doi.org\/10.1111\/andr.12196","journal-title":"Andrology"},{"key":"10851_CR138","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1210\/me.2005-0096","volume":"19","author":"Q Zhang","year":"2005","unstructured":"Zhang Q, Rubenstein JN, Jang TL et al (2005) Insensitivity to transforming growth factor-\u03b2 results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP). Mol Endocrinol 19:2390\u20132399. https:\/\/doi.org\/10.1210\/me.2005-0096","journal-title":"Mol Endocrinol"},{"key":"10851_CR139","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13046-018-0764-9","volume":"37","author":"H Zhou","year":"2018","unstructured":"Zhou H, Wu G, Ma X et al (2018) Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways. J Exp Clin Cancer Res 37:89. https:\/\/doi.org\/10.1186\/s13046-018-0764-9","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10851-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10851-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10851-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:49:29Z","timestamp":1786949369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-026-10851-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":139,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10851"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10851-x","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"200"}}